SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-20-000052
Filing Date
2020-09-14
Accepted
2020-09-14 16:01:53
Documents
44
Period of Report
2020-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20200914x8k.htm 8-K 39942
2 EX-99.1 sava-20200914xex99_1.htm EX-99.1 118084
3 EX-99.2 sava-20200914xex99_2.htm EX-99.2 94999
4 GRAPHIC sava-20200914xex99_1g001.jpg GRAPHIC 154458
5 GRAPHIC sava-20200914xex99_1g002.jpg GRAPHIC 300615
6 GRAPHIC sava-20200914xex99_1g003.jpg GRAPHIC 176516
7 GRAPHIC sava-20200914xex99_1g004.jpg GRAPHIC 116067
8 GRAPHIC sava-20200914xex99_1g005.jpg GRAPHIC 212042
9 GRAPHIC sava-20200914xex99_1g006.jpg GRAPHIC 151194
10 GRAPHIC sava-20200914xex99_1g007.jpg GRAPHIC 163080
11 GRAPHIC sava-20200914xex99_1g008.jpg GRAPHIC 169138
12 GRAPHIC sava-20200914xex99_1g009.jpg GRAPHIC 78030
13 GRAPHIC sava-20200914xex99_1g010.jpg GRAPHIC 141900
14 GRAPHIC sava-20200914xex99_1g011.jpg GRAPHIC 115536
15 GRAPHIC sava-20200914xex99_1g012.jpg GRAPHIC 138400
16 GRAPHIC sava-20200914xex99_1g013.jpg GRAPHIC 126702
17 GRAPHIC sava-20200914xex99_1g014.jpg GRAPHIC 151603
18 GRAPHIC sava-20200914xex99_1g015.jpg GRAPHIC 107683
19 GRAPHIC sava-20200914xex99_1g016.jpg GRAPHIC 153763
20 GRAPHIC sava-20200914xex99_1g017.jpg GRAPHIC 104267
21 GRAPHIC sava-20200914xex99_1g018.jpg GRAPHIC 143835
22 GRAPHIC sava-20200914xex99_1g019.jpg GRAPHIC 71079
23 GRAPHIC sava-20200914xex99_1g020.jpg GRAPHIC 92495
24 GRAPHIC sava-20200914xex99_1g021.jpg GRAPHIC 89968
25 GRAPHIC sava-20200914xex99_1g022.jpg GRAPHIC 103742
26 GRAPHIC sava-20200914xex99_1g023.jpg GRAPHIC 106073
27 GRAPHIC sava-20200914xex99_1g024.jpg GRAPHIC 101346
28 GRAPHIC sava-20200914xex99_1g025.jpg GRAPHIC 103471
29 GRAPHIC sava-20200914xex99_1g026.jpg GRAPHIC 109408
30 GRAPHIC sava-20200914xex99_1g027.jpg GRAPHIC 142758
31 GRAPHIC sava-20200914xex99_1g028.jpg GRAPHIC 117359
32 GRAPHIC sava-20200914xex99_1g029.jpg GRAPHIC 106724
33 GRAPHIC sava-20200914xex99_1g030.jpg GRAPHIC 78801
34 GRAPHIC sava-20200914xex99_1g031.jpg GRAPHIC 174445
35 GRAPHIC sava-20200914xex99_1g032.jpg GRAPHIC 100169
36 GRAPHIC sava-20200914xex99_1g033.jpg GRAPHIC 143686
37 GRAPHIC sava-20200914xex99_1g034.jpg GRAPHIC 113800
38 GRAPHIC sava-20200914xex99_1g035.jpg GRAPHIC 142802
39 GRAPHIC sava-20200914xex99_1g036.jpg GRAPHIC 99340
40 GRAPHIC sava-20200914xex99_1g037.jpg GRAPHIC 137660
41 GRAPHIC sava-20200914xex99_1g038.jpg GRAPHIC 136724
42 GRAPHIC sava-20200914xex99_1g039.jpg GRAPHIC 161890
43 GRAPHIC sava-20200914xex99_1g040.jpg GRAPHIC 153177
44 GRAPHIC sava-20200914xex99_2g001.jpg GRAPHIC 26443
  Complete submission text file 0001069530-20-000052.txt   7584251
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 201173194
SIC: 2834 Pharmaceutical Preparations